EP07.01. Can the Use of New Haemostatic Agent Improve Short Term Outcomes of Surgically Treated Non-small Cell Lung Cancer Patients? - PDF(Slides)
Back to course
Pdf Summary
Asset Subtitle
Sara Ricciardi
Meta Tag
Speaker Sara Ricciardi
Topic Early-Stage NSCLC: Best Practice
haemostatic agent
Microporous Polysaccharide Hemospheres
short-term outcomes
non-small cell lung cancer
retrospective analysis
linear regression analysis
blood loss reduction
hospital stay reduction
Powered By